Benzinga | May 12, 2021 04:40PM EDT

Evoke Pharma Q1 EPS $(0.08) Misses $(0.06) Estimate, Sales $90.00K Miss $830.00K Estimate

Evoke Pharma (NASDAQ:EVOK) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 14.29 percent decrease over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $90.00 thousand which missed the analyst consensus estimate of $830.00 thousand by 89.16 percent.